Clinical Trials
| Cancer Type: Anal | |
| Description: Phase II Trial of Cetuximab Plus Cisplatin, 5-Fluorouracil and Radiation in Immumocompetent Patients with Anal Carcinoma | |
| Entity Approving The Trial: Eastern Cooperative Oncology Group (ECOG) |
|
| Phase: II | |
| Site-Wide Accrual Goal: 50 | |
| Related Files | |
| No related files found. | |
| Related Links | |
| No related links found. |
 |
 |
|
